Syngene International opens COVID-19 RT-PCR testing centre at Bengaluru site

28 Apr 2020 Evaluate

Syngene International has opened a COVID-19 testing laboratory at its Bengaluru site. In less than six weeks, the company used its expertise in clinical trial management, human clinical sample testing procedures, molecular biology and viral testing to gain the additional approvals, including ICMR approval, necessary to open the facility to support hospitals in the city.

A dedicated team of scientists has been trained to perform these tests as per the guidelines prescribed by national and global regulatory authorities. Necessary processes have been established for safe handling of the samples and testing kits have been sourced and validated. With the broad range of scientific expertise in relevant disciplines that Syngene offers, it is also working to supply reagents, primers and probes for COVID-19 diagnostic testing to clients, as well as working on research projects related to vaccine development which could represent a longer-term solution for fighting the coronavirus pandemic.

Syngene International is India’s largest Contract Research Services Organization providing integrated discovery and development services for novel molecules across multiple platforms including small molecules, large molecules, Antibody-Drug Conjugates and Oligonucleotides.

Syngene Internation. Share Price

656.25 10.05 (1.56%)
18-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 656.25
Indegene 536.05
CMS Info Systems 348.65
Sagility 50.94
Smartworks Coworking 460.15
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×